Indoco Remedies Ltd
NSE:INDOCO

Watchlist Manager
Indoco Remedies Ltd Logo
Indoco Remedies Ltd
NSE:INDOCO
Watchlist
Price: 227.61 INR 0.42%
Market Cap: 21B INR

Indoco Remedies Ltd
Operating Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Indoco Remedies Ltd
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Indoco Remedies Ltd
NSE:INDOCO
Operating Income
-₹138.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Operating Income
₹67.3B
CAGR 3-Years
18%
CAGR 5-Years
16%
CAGR 10-Years
15%
Cipla Ltd
NSE:CIPLA
Operating Income
₹60.6B
CAGR 3-Years
22%
CAGR 5-Years
20%
CAGR 10-Years
10%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Operating Income
₹130.6B
CAGR 3-Years
16%
CAGR 5-Years
20%
CAGR 10-Years
9%
Lupin Ltd
NSE:LUPIN
Operating Income
₹51.6B
CAGR 3-Years
168%
CAGR 5-Years
35%
CAGR 10-Years
7%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Operating Income
₹31.9B
CAGR 3-Years
20%
CAGR 5-Years
13%
CAGR 10-Years
6%
No Stocks Found

Indoco Remedies Ltd
Glance View

Market Cap
21B INR
Industry
Pharmaceuticals

Indoco Remedies Ltd. engages in manufacturing and marketing of Formulations (Finished Dosage Forms) and active pharmaceutical ingredients. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2005-01-07. The firm is an integrated, research-oriented pharma company engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The firm's geographical segments include India and Outside India. The firm has nine domestic marketing divisions with a brand portfolio in various therapeutic segments, including Gastrointestinal, Respiratory, Anti-Infective, Stomatologicals, Ophthalmic, Nutritionals, Cardiovascular, Anti-Diabetics, Pain Management and Gyneacology. The Company’s brands include Cyclopam, Febrex Plus, Sensodent-K, Karvol Plus, ATM, Oxipod, Cital, Sensoform, Sensodent-KF, Cal-Aid, Cloben-G, Glychek, Kidodent, Carmicide, Rexidin, MCBM and Methycal.

INDOCO Intrinsic Value
339.68 INR
Undervaluation 33%
Intrinsic Value
Price

See Also

What is Indoco Remedies Ltd's Operating Income?
Operating Income
-138.5m INR

Based on the financial report for Mar 31, 2025, Indoco Remedies Ltd's Operating Income amounts to -138.5m INR.

Back to Top